U.S. markets open in 3 hours 14 minutes
  • S&P Futures

    3,677.50
    +13.00 (+0.35%)
     
  • Dow Futures

    30,060.00
    +128.00 (+0.43%)
     
  • Nasdaq Futures

    12,511.00
    +48.75 (+0.39%)
     
  • Russell 2000 Futures

    1,857.10
    +9.90 (+0.54%)
     
  • Crude Oil

    46.34
    +0.70 (+1.53%)
     
  • Gold

    1,843.20
    +2.10 (+0.11%)
     
  • Silver

    24.34
    +0.21 (+0.86%)
     
  • EUR/USD

    1.2176
    +0.0027 (+0.22%)
     
  • 10-Yr Bond

    0.9200
    0.0000 (0.00%)
     
  • Vix

    21.05
    -0.12 (-0.57%)
     
  • GBP/USD

    1.3468
    +0.0015 (+0.11%)
     
  • USD/JPY

    104.0040
    +0.1440 (+0.14%)
     
  • BTC-USD

    19,047.86
    -209.72 (-1.09%)
     
  • CMC Crypto 200

    374.32
    -0.09 (-0.02%)
     
  • FTSE 100

    6,547.32
    +57.05 (+0.88%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Paratek: 3Q Earnings Snapshot

·1 min read

BOSTON (AP) _ Paratek Pharmaceuticals Inc. (PRTK) on Thursday reported a loss of $20.9 million in its third quarter.

The Boston-based company said it had a loss of 46 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 61 cents per share.

The pharmaceutical company posted revenue of $13.7 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $11.9 million.

Paratek shares have increased 25% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.03, an increase of 27% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTK at https://www.zacks.com/ap/PRTK